Some compounds demonstrate antitumor properties against breast cancer cells by down-regulating the activity of the PI3K/Akt pathway, while studies have shown that down-regulation of multiple enzymes pertaining to the AA pathway can inhibit cell growth and apoptosis of breast cancer cells29, 83. The gene discussed is AKT1; the disease is breast carcinoma.